Enhanced oral bioavailability of vancomycin in rats treated with long-term parenteral nutrition
暂无分享,去创建一个
Keizo Fukushima | Asako Nishimura | N. Shibata | H. Ichikawa | Akira Okada | Asako Nishimura | Nobuhito Shibata | Nobuyuki Sugioka | Hideki Ichikawa | K. Fukushima | N. Sugioka | Yoriko Hayashi | Akira Okada | Yoriko Hayashi
[1] M. Alpert,et al. Significant Absorption of Oral Vancomycin in a Patient with Clostridium difficile Colitis and Normal Renal Function , 2006, Southern medical journal.
[2] D. Deleu,et al. Red man syndrome , 2002, Critical care.
[3] M. Alison,et al. Lower Insulin Secretory Response to Glucose Induced by Artificial Nutrition in Children: Prolonged and Total Parenteral Nutrition , 2007, Pediatric Research.
[4] H. Endeman,et al. Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study , 2011, Critical care.
[5] N. Matsuda,et al. Mechanisms of Inflammatory Response and Organ Dysfunction: Organ-Protective Strategy by Anesthetics. , 2014 .
[6] H. O. Oudemans-van Straaten,et al. Randomized clinical trial of perioperative selective decontamination of the digestive tract versus placebo in elective gastrointestinal surgery , 2011, The British journal of surgery.
[7] N. Shibata,et al. Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailability in rats. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] F. Boucher,et al. Possible Red-Man Syndrome Associated with Systemic Absorption of Oral Vancomycin in a Child with Normal Renal Function , 1994, The Annals of pharmacotherapy.
[9] Asako Nishimura,et al. Effect of intestinal atrophy and hepatic impairment induced by parenteral nutrition on drug absorption and disposition in rats. , 2015, JPEN. Journal of parenteral and enteral nutrition.
[10] M. Puder,et al. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions. , 2013, Advances in nutrition.
[11] I. Blasig,et al. Sodium caprate transiently opens claudin-5-containing barriers at tight junctions of epithelial and endothelial cells. , 2012, Molecular pharmaceutics.
[12] Yongjia Feng,et al. Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction , 2012, Annals of the New York Academy of Sciences.
[13] Yongjia Feng,et al. Decline in intestinal mucosal IL-10 expression and decreased intestinal barrier function in a mouse model of total parenteral nutrition. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[14] Kanji Takada,et al. Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats. , 2003, International journal of pharmaceutics.
[15] Yongjia Feng,et al. Enteral versus Parenteral Nutrition: Effect on Intestinal Barrier Function , 2009 .
[16] Xiaoyi Sun,et al. Impact of caloric intake on parenteral nutrition-associated intestinal morphology and mucosal barrier function. , 2006, JPEN. Journal of parenteral and enteral nutrition.
[17] I. Alia,et al. Enteral Vancomycin Controls Methicillin-resistant Staphylococcus Aureus Endemicity in an Intensive Care Burn Unit: A 9-Year Prospective Study , 2007, Annals of surgery.
[18] T Iga,et al. Effect of cilastatin on renal handling of vancomycin in rats. , 1998, Journal of pharmaceutical sciences.
[19] W. Qin,et al. Glycyl-glutamine-enriched long-term total parenteral nutrition attenuates bacterial translocation following small bowel transplantation in the pig. , 1999, The Journal of surgical research.
[20] C. Hvas,et al. Quality and safety impact on the provision of parenteral nutrition through introduction of a nutrition support team , 2014, European Journal of Clinical Nutrition.
[21] H. Harmsen,et al. Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients , 2010, Intensive Care Medicine.
[22] N. Matsuda,et al. Alert cell strategy: mechanisms of inflammatory response and organ protection. , 2014, Current pharmaceutical design.
[23] R. Polk,et al. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions , 1990, Antimicrobial Agents and Chemotherapy.
[24] H. Khalili,et al. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review , 2012, European Journal of Clinical Pharmacology.